Skip to main content

#161908

Capan-2 Cell line

Cat. #161908

Capan-2 Cell line

Cat. #: 161908

Availability: 8-10 weeks

Organism: Human

Tissue: Pancreas

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jorgen Fogh, James D. Loveless

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Kyriazis et al. 1986. Cancer Research. 46: 5810-5815. PMID: 3019537.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Capan-2 Cell line
  • Organism: Human
  • Gender: Male
  • Tissue: Pancreas
  • Donor: 56-year-old, White, male patient with pancreatic adenocarcinoma. The patient had received prior therapy with cytoxan, bleomycin and adriamycin.
  • Morphology: Polygonal
  • Growth properties: Adherent
  • Products or characteristics of interest: Isoenzymes: AK-1, 1; ES-D, 1; G6PD, B; GLO-I, 1-2; Me-2, 1; PGM1, 1; PGM3, 1-2
  • Description: Capan-2 is a human pancreatic ductal adenocarcinoma cell line. These cells grow in adherent tissue culture and display epithelial morphology. They form well-differentiated tumours when injected into immunocompromised mice and are used as a xenograft model for pancreatic cancer. The Capan-2 cells express mutant K-Ras (G12V) and elevated levels of the Epidermal Growth Factor Receptor (EGFR). In addition, they express wildtype p53 and normal levels of SMAD4 protein.
  • Application: 3D cell culture; High-throughput screening; Toxicology; Bioproduction; Cancer research
  • Biosafety level: 1

Target Details

  • Target: Antigen expression: Blood Type B; Rh+
  • Target background: Blood Type B; Rh+; high levels of MUC-1 mucin mRNA; low levels of MUC-2 mRNA; MUC-3 gene not expressed

Applications

  • Application: 3D cell culture; High-throughput screening; Toxicology; Bioproduction; Cancer research

Handling

  • Growth medium: McCoy's 5a Medium Modified supplemented with 10% FBS
  • Temperature: 37° C
  • Atmosphere: 95% Air, 5% CO2
  • Shipping conditions: Dry Ice
  • Storage medium: Culture medium 95%; DMSO, 5%
  • Storage conditions: Vapor phase of liquid nitrogen. Storage at -70° C will result in loss of viability.
  • Subculture routine: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks. Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended Medium Renewal: 2 to 3 times per week
  • Str profiling: Amelogenin: X;CSF1PO: 11,12;D13S317: 12;D16S539: 12,14;D5S818: 11;D7S820: 10,11;TH01: 6,9.3;TPOX: 8;vWA: 16,17;D3S1358: 15,18;D21S11: 28,30;D18S51: 14,17;Penta_E: 5,21;Penta_D: 9,16;D8S1179: 11,15;FGA: 25;D19S433: 12,13;D2S1338: 19

References

  • Kyriazis et al. 1986. Cancer Research. 46: 5810-5815. PMID: 3019537.
  • Deer et al. 2010. Pancreas. 39: 425-435. PMID: 20418756.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.